MATTHEW BAKER: Open Payments
NPI 1356349914 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 56 payments from 18 companies in 2025. Trend: 2023 $1,366 · 2024 $1,290 · 2025 $1,425
Food & beverage: $1,425
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 10 | $222 |
| Sumitomo Pharma America, Inc. | 9 | $221 |
| Boston Scientific Corporation | 4 | $159 |
| UROGEN PHARMA, INC. | 3 | $108 |
| ACCORD HEALTHCARE, INC. | 4 | $97 |
| Ferring Pharmaceuticals Inc. | 5 | $88 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $76 |
| TOLMAR, INC. | 3 | $76 |
| PFIZER INC. | 2 | $71 |
| Janssen Biotech, Inc. | 2 | $55 |
Products named: AVEED, GEMTESA, JELMYTO, Axonics, Camcevi, ADSTILADRIN, ORGOVYX, XTANDI.
Industry payments across NC — which companies pay providers there.
